Alnylam Licenses IP Covering RNAi Applications in Vaccines

The deals are with the Mount Sinai School of Medicine and the University of Queensland in Australia, which have been collaborating with the company on developing vaccines for flu and cancer.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.